Company profile
Bioelectronics Corporation
OTC: BIEL · Healthcare · Medical - Specialties
#935 of 1,418 Healthcare companies by revenuebottom-quartile growth
EA Score
——FH —DQ —GM —SS 50
v0.1 · 5/100 weight · pillars only
↑ listing tenure, disclosure history · ↓ balance-sheet leverage, Piotroski F
Methodology →Revenue TTM
$505.0k
Rev growth YoY (TTM)
-63.1%
Net income (FY)
-$930.6k
Employees
9
as of 2026-08-23
Market cap
$7.4M
as of 2026-08-23
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$496.0k$496.0k2024
Net income-$930.6k-$930.6k2024
Operating income-$392.7k-$392.7k2024
Total assets$43.3k$43.3k2024
Liabilities$17.5M$17.5M2024
Equity-$17.4M-$17.4M2024
Revenue trend
FY2017 – FY2024 · USD
FY17
FY18
FY19
FY20
FY21
FY22
FY23
FY24
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Bioelectronics Corporation’s revenue?
Bioelectronics Corporation booked $496.0k in FY2024 revenue, contracting 31% year over year — slower than 76% of Healthcare companies we track, at a -187.6% net margin.
Peers · Healthcare
DiaMedica Therapeutics Inc.35DZenith Capital Corp.——Imunon, Inc.39DPasithea Therapeutics Corp.32DPositron Corporation28DSpeedus Corp.——Neighbors
Frederick →Key facts
CEOKelly A. Whelan
SectorHealthcare
IndustryMedical - Specialties
HeadquartersFrederick, MD
ExchangeOTC: BIEL
Employees9
IPO date2004-04-12
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.